Major congenital malformations after first-trimester exposure to ACE inhibitors. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA (2006) N Engl J Med 354: 2443-51 Teratogen-mediated inhibition of target tissue response to Shh signaling. Cooper MK, Porter JA, Young KE, Beachy PA (1998) Science 280: 1603-7 Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition. Hubers SA, Brown NJ (2016) Circulation 133: 1115-24 Prenatal use of metronidazole and birth defects: no association. Piper JM, Mitchel EF, Ray WA (1993) Obstet Gynecol 82: 348-52 Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Piper JM, Ray WA, Rosa FW (1992) Obstet Gynecol 80: 429-32 p53 Signaling and cell cycle checkpoints. Stewart ZA, Pietenpol JA (2001) Chem Res Toxicol 14: 243-63 Prenatal alcohol exposure and interhemispheric transfer of tactile information: Detroit and Cape Town findings. Dodge NC, Jacobson JL, Molteno CD, Meintjes EM, Bangalore S, Diwadkar V, Hoyme EH, Robinson LK, Khaole N, Avison MJ, Jacobson SW (2009) Alcohol Clin Exp Res 33: 1628-37 Potential side effects of renin inhibitors--mechanisms based on comparison with other renin-angiotensin blockers. Cheng H, Harris RC (2006) Expert Opin Drug Saf 5: 631-41 NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Chapin RE, Adams J, Boekelheide K, Gray LE, Hayward SW, Lees PS, McIntyre BS, Portier KM, Schnorr TM, Selevan SG, Vandenbergh JG, Woskie SR (2008) Birth Defects Res B Dev Reprod Toxicol 83: 157-395
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.